BATS:CBOE
BATS:CBOECapital Markets

Did Cboe's (CBOE) Launch of Tech and Crypto Derivatives Just Redefine Its Growth Story?

Cboe Global Markets has announced plans to launch futures and options on its new Magnificent 10 Index and soon-to-trade Bitcoin and Ether Continuous Futures, both designed to offer cash-settled exposure to high-profile equities and digital asset markets for institutional investors. These launches enable market participants to manage risk across top technology stocks and key cryptocurrencies within single, flexible derivative contracts, signaling Cboe's expansion into innovative trading...
NasdaqCM:SLNO
NasdaqCM:SLNOBiotechs

A Look at Soleno Therapeutics (SLNO) Valuation Following $100 Million Share Buyback Announcement

Soleno Therapeutics (SLNO) has just announced a $100 million accelerated share repurchase agreement with Jefferies LLC. The company aims to buy back a sizable chunk of its common stock over the coming months. This move highlights management’s confidence in the company’s long-term outlook. See our latest analysis for Soleno Therapeutics. Soleno Therapeutics’ announcement comes after a period of volatility, with the share price down over 28% in the past month and more than 34% in the past...
NasdaqGS:REAL
NasdaqGS:REALSpecialty Retail

A Look at RealReal (REAL) Valuation Following Board Resignation and Major Investor Exit

RealReal (REAL) has seen changes at the board level, as Gilbert L. Baird III resigned from the Board of Directors on November 17. This follows GreyLion Partners LP's sale of its stake in the company. See our latest analysis for RealReal. It’s been a dramatic year for RealReal, and momentum now appears to be building. While the recent board changes and GreyLion’s exit shook things up, the company’s share price has soared 77% over the past 90 days and boasts a remarkable 1-year total...
NasdaqGS:AVGO
NasdaqGS:AVGOSemiconductor

A Closer Look at Broadcom (AVGO) Valuation Following Recent Share Price Surge

Broadcom (AVGO) shares saw some movement today, drawing investor attention as traders evaluated the company’s strong financial track record. With year-over-year revenue and net income growth, many are watching how the stock responds as market conditions continue to change. See our latest analysis for Broadcom. Broadcom’s stock has experienced an impressive burst of momentum, with a 1-day share price return of 11.1% and a 7-day return of 10.3%. This reflects growing investor optimism following...
NasdaqGS:KURA
NasdaqGS:KURABiotechs

Kura Oncology (KURA) Is Up 8.1% After FDA Clears First Targeted Therapy for NPM1-Mutated AML

On November 13, 2025, Kura Oncology and Kyowa Kirin announced that the FDA had granted full approval for KOMZIFTI (ziftomenib), the first once-daily targeted therapy for adults with relapsed or refractory NPM1-mutated acute myeloid leukemia, following positive results from the pivotal KOMET-001 trial. This approval addresses a significant unmet need in a patient group where around 30% of AML cases involve NPM1 mutations and treatment options have historically been limited. We'll examine how...
NasdaqGS:IREN
NasdaqGS:IRENSoftware

IREN (NasdaqGS:IREN): Evaluating Valuation After $9.7B Microsoft Deal and AI Infrastructure Pivot

IREN (NasdaqGS:IREN) is getting a lot of attention following its strategic pivot from bitcoin mining to powering AI cloud and GPU infrastructure. The $9.7 billion Microsoft contract signals how seriously the company is leaning into this transition. See our latest analysis for IREN. After rocketing higher earlier in the year, IREN’s share price has experienced some dramatic swings, especially after locking in that $9.7 billion Microsoft deal and announcing ambitious GPU expansion plans...
NasdaqGS:LITE
NasdaqGS:LITECommunications

US Stock Market Today: S&P 500 Futures Dip as Rate Cut Bets Battle Growth Worries

The Morning Bull - US Market Morning Update Tuesday, Nov, 25 2025 US stock futures are hinting lower this morning as cautious investors weigh two big signals from the overnight session. First, the yield on the 10-year US Treasury slipped to 4.04 percent, its lowest in a month. That number matters because it means borrowing is gradually getting cheaper, especially as Federal Reserve officials ramp up talk of a possible interest rate cut next month. On the other hand, economic figures out of...
NYSE:KO
NYSE:KOBeverage

How Coca-Cola’s Sustainability News Impacts Its 2025 Stock Valuation

Wondering if Coca-Cola’s stock is still a refreshing investment, or if the price has lost its fizz? You’re not alone. Let’s dive into what’s really behind the numbers. The stock has climbed 17.4% year-to-date and delivered a 16.1% return over the past year, showing strong momentum that has captured investors’ attention. Recent news around Coca-Cola’s strategic partnerships, sustainability initiatives, and high-level management changes has helped drive optimism, hinting at new growth...
NasdaqGM:INOD
NasdaqGM:INODProfessional Services

A Look at Innodata’s (INOD) Valuation After Record Q3 Results and Strengthening AI Partnerships

Innodata (INOD) just reported its best-ever third quarter, as revenues, profitability, and cash balances all reached new highs. The company’s CEO emphasized continued growth and deeper partnerships with major tech and AI players. See our latest analysis for Innodata. Innodata’s share price has surged 48.8% over the past three months, showing strong momentum as investors digest record quarterly results and optimism about its AI-driven growth. For investors thinking longer-term, the stock’s...
NasdaqGS:CHRD
NasdaqGS:CHRDOil and Gas

Chord Energy (CHRD): Valuation in Focus After Fresh ‘Outperform’ Analyst Coverage Spurs Investor Interest

Chord Energy (CHRD) just caught investors' attention as William Blair initiated coverage with an 'Outperform' rating. This vote of confidence, along with similar consensus from 19 firms, is driving fresh curiosity about the company's outlook. See our latest analysis for Chord Energy. Chord’s shares have seen some renewed momentum lately, climbing 1.85% in the past day and 3.44% across the last week. Meanwhile, the broader year-to-date share price return stands at -21.55%. That said,...
NYSE:FUL
NYSE:FULChemicals

H.B. Fuller (FUL): Exploring Valuation as Analyst Coverage Highlights Challenges and Margin Opportunity

H.B. Fuller stock is in the spotlight after UBS began coverage with a Neutral rating, citing ongoing growth challenges. Seaport Global Securities upgraded the company to Buy, pointing to room for margin improvement ahead. See our latest analysis for H.B. Fuller. H.B. Fuller's share price has lost ground this year, dipping 9% year-to-date and falling 26% on a total return basis over the past twelve months. Mixed analyst opinions and ongoing margin challenges have weighed on market sentiment...
NYSE:IBM
NYSE:IBMIT

Is IBM Fairly Priced After Recent AI and Cloud Partnership News in 2025?

Ever wondered if International Business Machines is a smart buy at today’s prices? Let’s break down the numbers and see if there’s hidden value waiting to be uncovered. IBM’s stock has been on a rollercoaster lately, rising 2.3% over the past week, but posting a modest 1.1% loss in the last 30 days. The year-to-date return still stands at an impressive 38.3%. Recent headlines highlight IBM’s push into artificial intelligence and cloud technology partnerships, including new collaborations to...
NYSE:BSX
NYSE:BSXMedical Equipment

Boston Scientific (BSX): Assessing Fair Value After Recent Share Price Pullback

Boston Scientific (BSX) has seen its stock price fluctuate over the past month, edging down by 3% despite positive annual revenue and net income growth. Investors may be weighing long-term performance against recent market sentiment. See our latest analysis for Boston Scientific. Despite some short-term pullback, Boston Scientific has delivered a strong year, with its share price up close to 10% year-to-date and a total shareholder return of nearly 10% over the past twelve months. Momentum...
NasdaqGS:PLTR
NasdaqGS:PLTRSoftware

Palantir Technologies (PLTR) Is Down 5.3% After Record Revenue Jump and Major US Army Contract

Palantir Technologies reported a record quarter featuring a 62.8% year-over-year revenue increase and a very large rise in net income, fueled by major U.S. Army and Air Force contracts and rapid growth in commercial enterprise clients. This momentum was further highlighted by expanded partnerships with industry leaders like Nvidia, as well as key certifications such as the IRAP PROTECTED level in Australia, which extends Palantir's access to government and commercial opportunities in...
NasdaqGS:BGC
NasdaqGS:BGCCapital Markets

BGC Group (BGC): Valuation in Focus After Revenue Misses Expectations Despite Strong Growth

BGC Group (BGC) released its latest financial results, showing revenue growth of 31% compared to a year ago. However, the figures fell short of market expectations, particularly on EBITDA and revenue metrics. This led to a sell-off. See our latest analysis for BGC Group. BGC Group’s share price has been losing momentum in recent months, dropping 9.5% over the past 30 days and 16.3% in the last quarter, bringing its 1-year total shareholder return to -12%. However, longer-term investors are...